Joseph Jimenez - 24 Jun 2021 Form 3 Insider Report for Graphite Bio, Inc. (GRPH)

Role
Director
Signature
/s/ Franco Valle, attorney-in-fact
Issuer symbol
GRPH
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
3
Filing time
24 Jun 2021, 21:20:02
Previous filing
17 Jun 2021
Next filing
15 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GRPH Common Stock 154K 24 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GRPH Series B Preferred Stock 24 Jun 2021 Common Stock 8.13K Direct F1
holding GRPH Stock Option (right to buy) 24 Jun 2021 Common Stock 12.5K $6.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's Series B Preferred Stock will automatically convert on a 2.432-for-one basis into the number of shares of the Issuer's common stock shown in Column 3 immediately upon closing of the Issuer's initial public offering without payment of additional consideration. The Series B Preferred Stock has no expiration date.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Remarks:

Exhibit 24 - Power of Attorney